Share this page on LinkedIn
Share This Page on Google+
Share This Page on Twitter
tell someone about this page print this page
You are here: Contents > 2015 > Volume 24 Number 5 September 2015 > DEVICE EVALUATION > Evaluation of p53 Polymorphism in Patients with Pannus-Derived Prosthetic Dysfunction

Evaluation of p53 Polymorphism in Patients with Pannus-Derived Prosthetic Dysfunction

Mustafa Ozan Gursoy1, Suleyman Karakoyun1,2, Macit Kalcık1, Mahmut Yesin1, Sabahattin Gunduz1, Mehmet Ali Astarcıoğlu1, Ali Emrah Oğuz1, Mehmet Ozkan1,2

1Department of Cardiology, Koşuyolu Kartal Heart Training and Research Hospital, Istanbul, 2Department of Cardiology, Kars Kafkas University, Faculty of Medicine, Kars, Turkey

Background and aim of the study: Prosthetic valve dysfunction (PVD) due to pannus formation is considered to occur due to a bioreaction to prosthetic material. The p53 gene plays a critical role in apoptosis and cell proliferation. p53 Arg72Pro polymorphism has been found to be associated with coronary stent restenosis, but has not yet been studied in prosthetic heart valve dysfunction. The study aim was to evaluate the association between pannus-derived PVD and p53 G72C(Arg72Pro) polymorphism.

Methods: This single-center, prospective study included 25 patients (20 females, five males; mean age 45.6 ± 12.5 years; group 1) who underwent redo valve surgery due to PVD, and 49 age- and gender-matched control patients (44 females, five males; mean age 47.3 ± 12.2 years; group 2) with normofunctional prostheses. The prostheses were examined using transthoracic and transesophageal echocardiography. Analyses of p53 G72C(Arg72Pro)

polymorphism were performed using Roche LightCyler 2.0 Real-time polymerase chain reaction.

Results: The most common location of replaced valves was the mitral position in both groups (88% and 89.8%, respectively). In group 1, normal alleles (GG) were observed in 12 patients (48%), while one patient (4%) showed a homozygous mutation (GC) and 12 patients (48%) showed a heterozygous mutation (CC). In group 2, 21 patients (42.9%) had normal alleles (GG), while four (8.2%) had a homozygous mutation (CC) and 24 (48.9%) had a heterozygous mutation (GC). No significant difference was observed between the groups with regards to p53 Arg72Pro polymorphism (p = 0.769).

Conclusion: In patients with prosthetic valves, the underlying mechanism behind pannus formation is unrelated to p53 Arg72Pro polymorphism.

The Journal of Heart Valve Disease 2015;24:604-611


Evaluation of p53 Polymorphism in Patients with Pannus-Derived Prosthetic Dysfunction

Click the above hyperlink to view the article, right click (Ctrl click on a Mac) to open in a new browser window or tab.

Purchase this Article

Please click the button below to purchase this article. Single article purchases are provided at $50.00 per article. Upon clicking the button below, single article user account subscription details are requested and, upon successful payment, a single article user account is created. Single articles are availble in your account for seven days after purchase.